SCHEMBL16640932

SCHEMBL16640932

CCCCOc1ccc(C(c2ccc(OCC3CO3)cc2)C(c2ccc(OCC3CO3)cc2)c2ccc(OCC3CO3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
TP53 P04637 3/20 0.53
TSHR P16473 3/20 0.53
MAPT P10636 2/20 0.53
HPGD P15428 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
HIF1A Q16665 2/20 0.53
CYP1A2 P05177 2/20 0.53
PPARG P37231 1/20 0.53
TDP1 Q9NUW8 2/20 0.51
PKM P14618 2/20 0.49
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
CYP3A4 P08684 1/20 0.46
SLC2A1 P11166 2/20 0.42
MAPK1 P28482 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16641005 1.00 ALDH1A1 (0.53) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL16640928 1.00 ALDH1A1 (0.53) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL16640929 1.00 ALDH1A1 (0.53) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL16641006 0.94 ALDH1A1 (0.48) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL23918988 0.91 ALDH1A1 (0.53) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL16640920 0.91 ALDH1A1 (0.53) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL16640918 0.91 ALDH1A1 (0.53) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL19607361 0.91 ALDH1A1 (0.62) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL7120531 0.91 ALDH1A1 (0.62) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL11714028 0.91 ALDH1A1 (0.62) ALDH1A1TP53TSHRMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200331934-A1 PREPARATION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP KOREA INST IND TECH (KR) 2020-10-22 US disclosed
US-9902803-B2 Epoxy compound having alkoxy silyl group, composition comprising same, cured product, use thereof and method for preparing epoxy compound having alkoxy silyl group KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2018-02-27 US disclosed
US-20150105493-A1 EPOXY COMPOUND HAVING ALKOXY SILYL GROUP, COMPOSITION COMPRISING SAME, CURED PRODUCT, USE THEREOF AND METHOD FOR PREPARING EPOXY COMPOUND HAVING ALKOXY SILYL GROUP KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2015-04-16 US disclosed
US-20150105493-A1 EPOXY COMPOUND HAVING ALKOXY SILYL GROUP, COMPOSITION COMPRISING SAME, CURED PRODUCT, USE THEREOF AND METHOD FOR PREPARING EPOXY COMPOUND HAVING ALKOXY SILYL GROUP KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331934-A1 PREPARATION METHOD FOR EPOXY COMPOUND HAVING ALKOXYSILYL GROUP ALK, ALKBH3, PHOSPHO1 ALDH1A1 1083/4885TP53 2925/4885TSHR 3978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.